These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 14652823

  • 1. Activating Gs alpha mutation at the Arg201 codon in liposclerosing myxofibrous tumor.
    Matsuba A, Ogose A, Tokunaga K, Kawashima H, Hotta T, Urakawa S, Umezu H, Higuchi T, Endo N.
    Hum Pathol; 2003 Nov; 34(11):1204-9. PubMed ID: 14652823
    [Abstract] [Full Text] [Related]

  • 2. [Bone liposclerosing myxofibrous tumor. Case presentation and literature review].
    Técualt-Gómez R, Atencio-Chan A, Cario-Méndez AG, Amaya-Zepeda RA, Balderas-Martinez J, González-Valladares JR.
    Acta Ortop Mex; 2015 Nov; 29(3):191-5. PubMed ID: 26999973
    [Abstract] [Full Text] [Related]

  • 3. A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to Gsalpha mutation at the Arg201 codon: polymerase chain reaction-restriction fragment length polymorphism analysis of paraffin-embedded tissues.
    Sakamoto A, Oda Y, Iwamoto Y, Tsuneyoshi M.
    J Mol Diagn; 2000 May; 2(2):67-72. PubMed ID: 11272890
    [Abstract] [Full Text] [Related]

  • 4. Liposclerosing myxofibrous tumour: a traumatized variant of fibrous dysplasia? Report of four cases and review of the literature.
    Heim-Hall JM, Williams RP.
    Histopathology; 2004 Oct; 45(4):369-76. PubMed ID: 15469475
    [Abstract] [Full Text] [Related]

  • 5. Juxta-articular myxoma and intramuscular myxoma are two distinct entities. Activating Gs alpha mutation at Arg 201 codon does not occur in juxta-articular myxoma.
    Okamoto S, Hisaoka M, Meis-Kindblom JM, Kindblom LG, Hashimoto H.
    Virchows Arch; 2002 Jan; 440(1):12-5. PubMed ID: 11942570
    [Abstract] [Full Text] [Related]

  • 6. Activating Gs(alpha) mutation in intramuscular myxomas with and without fibrous dysplasia of bone.
    Okamoto S, Hisaoka M, Ushijima M, Nakahara S, Toyoshima S, Hashimoto H.
    Virchows Arch; 2000 Aug; 437(2):133-7. PubMed ID: 10993273
    [Abstract] [Full Text] [Related]

  • 7. [Liposclerosing myxofibrous tumor of bone: a clinicopathologic analysis].
    Zhou J, Hu D, Jiang Z, Zhang H.
    Zhonghua Bing Li Xue Za Zhi; 2016 Jan; 45(1):21-4. PubMed ID: 26791549
    [Abstract] [Full Text] [Related]

  • 8. Liposclerosing myxofibrous tumor: a radiologic-pathologic-distinct fibro-osseous lesion of bone with a marked predilection for the intertrochanteric region of the femur.
    Kransdorf MJ, Murphey MD, Sweet DE.
    Radiology; 1999 Sep; 212(3):693-8. PubMed ID: 10478234
    [Abstract] [Full Text] [Related]

  • 9. Gsalpha gene mutations in monostotic fibrous dysplasia of bone and fibrous dysplasia-like low-grade central osteosarcoma.
    Pollandt K, Engels C, Kaiser E, Werner M, Delling G.
    Virchows Arch; 2001 Aug; 439(2):170-5. PubMed ID: 11561757
    [Abstract] [Full Text] [Related]

  • 10. Activating GNAS mutations in parosteal osteosarcoma.
    Carter JM, Inwards CY, Jin L, Evers B, Wenger DE, Oliveira AM, Fritchie KJ.
    Am J Surg Pathol; 2014 Mar; 38(3):402-9. PubMed ID: 24525511
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome.
    Shenker A, Weinstein LS, Sweet DE, Spiegel AM.
    J Clin Endocrinol Metab; 1994 Sep; 79(3):750-5. PubMed ID: 8077356
    [Abstract] [Full Text] [Related]

  • 15. Liposclerosing Myxofibrous Tumor: A Review.
    Deel C, Hassell L.
    Arch Pathol Lab Med; 2016 May; 140(5):473-6. PubMed ID: 27128305
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Investigation of the GSalpha gene in the diagnosis of fibrous dysplasia.
    Perdigão PF, Pimenta FJ, Castro WH, De Marco L, Gomez RS.
    Int J Oral Maxillofac Surg; 2004 Jul; 33(5):498-501. PubMed ID: 15183415
    [Abstract] [Full Text] [Related]

  • 19. The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks.
    Riminucci M, Liu B, Corsi A, Shenker A, Spiegel AM, Robey PG, Bianco P.
    J Pathol; 1999 Jan; 187(2):249-58. PubMed ID: 10365102
    [Abstract] [Full Text] [Related]

  • 20. Quantitative analysis of activating alpha subunit of the G protein (Gsα) mutation by pyrosequencing in fibrous dysplasia and other bone lesions.
    Liang Q, Wei M, Hodge L, Fanburg-Smith JC, Nelson A, Miettinen M, Foss RD, Wang G.
    J Mol Diagn; 2011 Mar; 13(2):137-42. PubMed ID: 21354047
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.